Splitting single-use drug vials among patients is clinical, coding no-no

Why This Topic Matters

Improper handling of single-use vial billing can create overpayment, compliance, and False Claims Act exposure. The article also highlights that payer policies may differ, so billing teams need to recognize general Medicare principles alongside local contractor guidance.

Article Sections

1. Overview of single-use vial billing and compliance risk

   Introduces the topic of billing for drugs and biologicals packaged in single-use vials and the compliance concerns raised by improper handling. Summarizes the general scenario discussed in the article.

2. Case settlement involving infliximab billing

   Describes a reported Medicare settlement related to billing practices for a biologic and the role of a whistleblower complaint. Provides the enforcement context for the article.

3. Medicare policy on discarded drug payment

   Reviews Medicare guidance on payment when part of a single-use vial is discarded after administration. Notes the broader policy framework for drug wastage reporting.

4. Claim submission and MAC-specific reporting approaches

   Explains that claim-line handling for discarded drug may vary by payer and references differing contractor instructions. Highlights that local payer policies can affect how billing is reported.

5. Official resources

   Lists external references cited in the article for safety, manual guidance, and payer policy materials. Serves as a source list rather than substantive coding guidance.